Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: i-node who wrote (721648)	7/16/2020 4:58:12 PM
From: steve harris	Read Replies (1) \| Respond to of 793759

Our RINO guv just locked down Arkansas...... fox16.com

To: i-node who wrote (721648)	7/16/2020 11:40:32 PM
From: skinowski	3 Recommendations Recommended By i-node Stock Puppy Thomas M. Read Replies (2) \| Respond to of 793759

It’s disappointing that while patients on HCQ did somewhat better, the improvement fell short of being statistically significant. One issue I see is their patient's age. Median age was 40 years. The interquartile age was 32 to 50 years. In other words, 25% were under 32, and 25% over 50 (usually, the bulk would be the 50 to 65 year old group. So... the study shows that among a group of mostly young outpatients (75% under 50) Improvements in the clinical course we’re not statistically significant. If they had more patients, maybe they’d get significant results - but, they say they couldn’t get more patients. PS - in the discussion they actually mention that the treatment might have worked better in an older group.